Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Cosmo Pharmaceuticals, Julius Baer, Zurich: Swiss Equity Preview

Don't Miss Out —
Follow us on:

Nov. 8 (Bloomberg) -- The following is a list of companies whose shares may have unusual price changes in Zurich. Stock symbols are in parentheses after company names. Share prices are from the last close.

The Swiss Market Index of the biggest and most actively traded companies lost 0.1 percent to 6,587.72. The broader Swiss Performance Index also fell 0.1 percent to 5,857.47.

Cosmo Pharmaceuticals SpA (COPN SW): The company’s experimental ulcerative colitis medicine budesonide MMX met the primary endpoint of a late stage study. Cosmo will file the treatment for approval in the U.S. and Europe in 2011. The shares rose 1.1 percent to 18.20 Swiss francs.

Julius Baer Group Ltd. (BAER VX): Shares in the 120-year-old Swiss private bank were cut to “neutral” from “buy” at BofA Merrill Lynch Global Research. The shares added 0.6 percent to 41.52 francs.

Zurich Financial Services AG (ZURN VX): Switzerland’s largest insurer said it has exercised an option to redeem $1 billion of subordinated debt early. Zurich will redeem two so-called enhanced capital-advantaged preferred securities, or ECAPS, valued at $600 million and $400 million and issued in December 2005 by U.S. subsidiaries. The shares dropped 1.2 percent to 235.40 francs.

To contact the reporter on this story: Alexis Xydias in London at axydias@bloomberg.net.

To contact the editor responsible for this story: David Merritt at dmerritt1@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.